FVLAX
Price
$20.88
Change
-$0.06 (-0.29%)
Updated
Sep 5 closing price
Net Assets
27.17M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

FVLAX vs VVIAX

Header iconFVLAX vs VVIAX Comparison
Open Charts FVLAX vs VVIAXBanner chart's image
Fidelity Advisor Value Leaders A
Price$20.88
Change-$0.06 (-0.29%)
VolumeN/A
Net Assets27.17M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
FVLAX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FVLAX vs. VVIAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVLAX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. FVLAX (27.2M). VVIAX pays higher dividends than FVLAX: VVIAX (2.10) vs FVLAX (1.34). FVLAX was incepted earlier than VVIAX: FVLAX (22 years) vs VVIAX (25 years). FVLAX (1.37) is less costly to investors than VVIAX (0.05). FVLAX is a more actively managed with annual turnover of: 32.00 vs. VVIAX (9.00). FVLAX has a lower initial minimum investment than VVIAX: FVLAX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. FVLAX (-9.10). VVIAX return over 5 years is better than : 70.16 vs. FVLAX (33.89).
FVLAXVVIAXFVLAX / VVIAX
Total Expense Ratio1.150.052,300%
Annual Report Gross Expense Ratio1.370.052,740%
Fund Existence22 years25 years-
Gain YTD4.1407.85053%
Front Load6%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.2M203B0%
Annual Yield % from dividends1.342.1064%
Returns for 1 year-9.107.74-118%
Returns for 3 years6.8136.6119%
Returns for 5 years33.8970.1648%
Returns for 10 years38.30131.6129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity